• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿块形成加肝内胆管癌导管周围浸润型的手术结果:与典型肿块形成型肝内胆管癌的比较研究

Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma.

作者信息

Shimada Kazuaki, Sano Tsuyoshi, Sakamoto Yoshihiro, Esaki Minoru, Kosuge Tomoo, Ojima Hidenori

机构信息

Department of Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.

出版信息

World J Surg. 2007 Oct;31(10):2016-22. doi: 10.1007/s00268-007-9194-0.

DOI:10.1007/s00268-007-9194-0
PMID:17687597
Abstract

BACKGROUND

The purpose of this study was to clarify the clinicopathologic characteristics and surgical outcomes of patients with the mass-forming (MF) plus periductal infiltrating (PI) type of intrahepatic cholangiocellular carcinoma (ICC).

METHODS

Between January 1, 1998, and December 31, 2004, a total of 94 patients with ICC underwent macroscopic curative resection, and the macroscopic type of the tumors was assessed prospectively. Among the 74 patients with the MF type (n = 46) and the MF plus PI type (n = 28) of ICC, multivariate analysis was conducted to identify the potential prognostic factors. The clinicopathologic data of the two groups were compared.

RESULTS

The results revealed two independent prognostic factors: presence/absence of intrahepatic metastasis and the macroscopic type of the tumor. ICCs categorized macroscopically as the MF plus PI type were significantly associated with jaundice (p < 0.001), bile duct invasion (p < 0.001), portal vein invasion (p = 0.025), lymph node involvement (p = 0.017), and positive surgical margin (p = 0.038).

CONCLUSION

Identification of the macroscopic type of the tumor is useful for predicting survival after hepatectomy in patients with ICC. The MF plus PI type of ICC appears to have a more unfavorable prognosis, even after radical surgery, than the MF type of ICC.

摘要

背景

本研究旨在阐明肿块形成(MF)加肝内胆管周围浸润(PI)型肝内胆管癌(ICC)患者的临床病理特征及手术疗效。

方法

1998年1月1日至2004年12月31日期间,共有94例ICC患者接受了宏观根治性切除术,并对肿瘤的宏观类型进行了前瞻性评估。在74例MF型(n = 46)和MF加PI型(n = 28)的ICC患者中,进行多因素分析以确定潜在的预后因素。比较两组的临床病理数据。

结果

结果显示两个独立的预后因素:肝内转移的有无和肿瘤的宏观类型。宏观分类为MF加PI型的ICC与黄疸(p < 0.001)、胆管侵犯(p < 0.001)、门静脉侵犯(p = 0.025)、淋巴结受累(p = 0.017)及手术切缘阳性(p = 0.038)显著相关。

结论

确定肿瘤的宏观类型有助于预测ICC患者肝切除术后的生存情况。MF加PI型ICC即使在根治性手术后,其预后似乎也比MF型ICC更差。

相似文献

1
Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma.肿块形成加肝内胆管癌导管周围浸润型的手术结果:与典型肿块形成型肝内胆管癌的比较研究
World J Surg. 2007 Oct;31(10):2016-22. doi: 10.1007/s00268-007-9194-0.
2
Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.肝内胆管癌:手术切除后的预后因素
World J Surg. 2009 Jun;33(6):1247-54. doi: 10.1007/s00268-009-9970-0.
3
Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion.对于无肝门侵犯的导管周围浸润型肝内胆管癌,手术治疗的效果优于无肝门侵犯的肿块型肝内胆管癌。
Hepatogastroenterology. 2010 Nov-Dec;57(104):1333-6.
4
Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement.肝内胆管细胞癌淋巴结无转移患者肝切除术中淋巴结清扫的治疗价值
Surgery. 2009 Apr;145(4):411-6. doi: 10.1016/j.surg.2008.11.010. Epub 2009 Feb 23.
5
Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma?大体外观能提示肝内胆管癌的预后吗?
J Surg Oncol. 1998 Nov;69(3):162-7. doi: 10.1002/(sici)1096-9098(199811)69:3<162::aid-jso8>3.0.co;2-l.
6
Periductal infiltrating type of intrahepatic cholangiocarcinoma: a rare macroscopic type without any apparent mass.肝内胆管细胞癌的导管周围浸润型:一种罕见的无明显肿块的大体类型。
Surg Today. 2012 Dec;42(12):1189-94. doi: 10.1007/s00595-012-0145-5. Epub 2012 Feb 21.
7
Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.肝内胆管癌的大体类型:临床病理特征及手术结果
Hepatogastroenterology. 2002 Mar-Apr;49(44):326-9.
8
Clinicopathological characteristics of intrahepatic cholangiocellular carcinoma presenting intrahepatic bile duct growth.呈现肝内胆管生长的肝内胆管细胞癌的临床病理特征
J Surg Oncol. 2009 Mar 1;99(3):161-5. doi: 10.1002/jso.21214.
9
Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.肝内胆管癌术后肝脏复发的预测因素
J Gastroenterol. 2006 Sep;41(9):893-900. doi: 10.1007/s00535-006-1877-z.
10
Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology.肝内胆管癌的肝切除术:与大体肿瘤形态的关系
Hepatogastroenterology. 2001 Jul-Aug;48(40):1129-33.

引用本文的文献

1
Comparison of prognostic factors and their differences in intrahepatic, hilar, and distal cholangiocarcinoma: A systematic review and meta-analysis.肝内、肝门部和肝外胆管癌预后因素及其差异的比较:一项系统评价和荟萃分析。
World J Gastrointest Oncol. 2025 Jul 15;17(7):107995. doi: 10.4251/wjgo.v17.i7.107995.
2
Management of intrahepatic cholangiocarcinoma: a review for clinicians.肝内胆管癌的管理:临床医生综述
Gastroenterol Rep (Oxf). 2025 Jan 26;13:goaf005. doi: 10.1093/gastro/goaf005. eCollection 2025.
3
Recommendations on maximising the clinical value of tissue in the management of patients with intrahepatic cholangiocarcinoma.

本文引用的文献

1
Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma.淋巴结转移数量是肝内胆管癌的一个重要预后因素。
World J Surg. 2005 Jun;29(6):728-33. doi: 10.1007/s00268-005-7761-9.
2
Positive microscopic margins alter outcome in lymph node-negative cholangiocarcinoma when resection is combined with adjuvant radiotherapy.当手术切除联合辅助放疗时,显微镜下切缘阳性会改变淋巴结阴性胆管癌的预后。
Am J Clin Oncol. 2005 Feb;28(1):21-3. doi: 10.1097/01.coc.0000139017.90599.f5.
3
Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period.
关于在肝内胆管癌患者管理中最大化组织临床价值的建议。
JHEP Rep. 2024 Mar 12;6(6):101067. doi: 10.1016/j.jhepr.2024.101067. eCollection 2024 Jun.
4
Surgical interpretation of the WHO subclassification of intrahepatic cholangiocarcinoma: a narrative review.世界卫生组织肝内胆管癌亚型分类的外科解读:一篇综述
Surg Today. 2025 Jan;55(1):1-9. doi: 10.1007/s00595-024-02825-x. Epub 2024 Apr 2.
5
Intrahepatic cholangiocarcinoma initially diagnosed as adenocarcinoma of unknown primary with hepatoduodenal ligament lymph node metastases: A case report.最初诊断为不明原发腺癌伴肝十二指肠韧带淋巴结转移的肝内胆管癌:一例报告。
Oncol Lett. 2023 Nov 8;27(1):7. doi: 10.3892/ol.2023.14140. eCollection 2024 Jan.
6
A Paradigm Shift in Primary Liver Cancer Therapy Utilizing Genomics, Molecular Biomarkers, and Artificial Intelligence.利用基因组学、分子生物标志物和人工智能实现原发性肝癌治疗的范式转变。
Cancers (Basel). 2023 May 17;15(10):2791. doi: 10.3390/cancers15102791.
7
Radiological Shape of the Tumor Predicts Progression and Survival in Resected Extrahepatic Cholangiocarcinoma.肿瘤的放射学形态可预测肝外胆管癌切除术后的进展和生存。
J Gastrointest Surg. 2023 Jun;27(6):1113-1121. doi: 10.1007/s11605-023-05614-y. Epub 2023 Feb 7.
8
Locoregional Approaches in Cholangiocarcinoma Treatment.胆管癌治疗中的局部区域治疗方法。
Cancers (Basel). 2022 Nov 28;14(23):5853. doi: 10.3390/cancers14235853.
9
Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand.肝门周围胆管癌第八版美国癌症联合委员会/国际抗癌联盟分期系统的修订:来自泰国东北部胆管癌高发地区的一种替代性病理分期系统。
Front Med (Lausanne). 2022 Sep 30;9:893252. doi: 10.3389/fmed.2022.893252. eCollection 2022.
10
Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma.日本肝癌研究组肝内胆管癌临床实践指南
Liver Cancer. 2022 Feb 23;11(4):290-314. doi: 10.1159/000522403. eCollection 2022 Jul.
肝内胆管细胞癌(ICC)扩大肝切除术:何时值得进行?一项单中心5年期间对50例患者进行27例切除术的经验。
Ann Surg. 2005 Jan;241(1):134-43. doi: 10.1097/01.sla.0000149426.08580.a1.
4
Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma.肝内导管乳头状型周围胆管癌的肝切除术。
Ann Surg Oncol. 2004 Jun;11(6):606-11. doi: 10.1245/ASO.2004.04.028.
5
The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy.肝肿瘤淋巴结清扫术的作用:关于治疗策略适宜性的进一步思考
Ann Surg. 2004 Feb;239(2):202-9. doi: 10.1097/01.sla.0000109154.00020.e0.
6
Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.肝内胆管癌:大体类型及分期分类
J Hepatobiliary Pancreat Surg. 2003;10(4):288-91. doi: 10.1007/s00534-002-0732-8.
7
Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.肝内胆管癌的外科治疗结果及影响生存的临床病理因素
Br J Surg. 2002 Dec;89(12):1525-31. doi: 10.1046/j.1365-2168.2002.02268.x.
8
A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables.一种用于肿块型肝内胆管癌的新分期系统:术前和术后变量分析
Cancer. 2001 Nov 1;92(9):2374-83. doi: 10.1002/1097-0142(20011101)92:9<2374::aid-cncr1585>3.0.co;2-l.
9
Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma.肝内胆管癌切除术中淋巴结清扫的价值
Br J Surg. 2001 Nov;88(11):1463-6. doi: 10.1046/j.0007-1323.2001.01879.x.
10
Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.美国原发性肝内胆管癌的发病率和死亡率不断上升。
Hepatology. 2001 Jun;33(6):1353-7. doi: 10.1053/jhep.2001.25087.